Fujifilm Holdings shares experienced a historic decline last Friday, posting the worst performance in the brand's entire history. Quotes plummeted by 18% amid disappointing quarterly results that came in significantly below market expectations.
Reasons for the failure: operating profit fell short of forecasts
The company's operating profit for the quarter ending in June amounted to 51.2 billion yen ($323 million). This is significantly below the average analyst forecast, which stood at 77.1 billion yen. The main factors putting pressure on the results were rising raw material costs and one-time expenses. Additionally, base profit declined in the healthcare and business solutions segments, indicating systemic problems rather than just temporary difficulties.
Experts agree that recovery to previous profitability levels will require significantly more time than previously assumed. First-quarter results demonstrate a further deterioration in profitability in the manufacturing and engineering divisions, and expecting a sharp rebound by the end of the fiscal year in March 2028 would be overly optimistic.
Rescue strategy: spin-off of a key division
In response to the crisis, Fujifilm's management announced plans for a partial spin-off of the Fujifilm Business Innovation division (formerly known as Fuji Xerox), which generates approximately 35% of the company's total revenue. Under the proposed scheme, Fujifilm will retain a stake of just under 20%, while the remaining shares will be distributed to shareholders as a dividend in kind. Subsequently, the division will be listed on the Tokyo Stock Exchange.
The implementation of this initiative will take two to three years and will require shareholder approval, as well as compliance with Japanese tax legislation requirements. It is important to note that the Fujifilm brand will be retained in the spun-off division. This step is part of the broader VISION2030 strategy, which prioritizes profitability and capital efficiency over simply increasing revenue.
Fujifilm is not the only company facing pressure this earnings season. Kioxia's shares also collapsed after revising forecasts, although some analysts remain optimistic about its recovery.
The situation in the Japanese market remains uncertain: the earnings season has been challenging for many issuers, and investors are not yet rushing to support restructuring plans. The question of whether the business division spin-off will become a lifeline for Fujifilm or merely delay the inevitable remains open.
My view: The decision to spin off Fujifilm Business Innovation is a bold but logical step. It will allow the parent company to focus on high-margin areas such as healthcare and materials, while the spun-off business can attract independent financing. However, the success of this strategy will depend on Fujifilm's ability to address operational issues in the short term. The market does not forgive empty promises, and investors should closely monitor the execution of the plan, not just its announcement.